The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits
Protein Science · 2023-10 · 32 (10)
DOI: 10.1002/pro.4754 ↗At a glance
Journal article in Protein Science, published online on 2023-09-20. Written by Suzanne G Mays and 3 co-authors. Institution: Department of Biochemistry, Emory University, Atlanta, Georgia, USA. Major MEDLINE topics: Receptors, Cytoplasmic and Nuclear, Transcription Factors. Cited 10 times so far (Crossref); 57 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: NIDDK NIH HHS, Burroughs Wellcome Fund, National Institutes of Health.
Abstract (original language)
Nuclear receptors (NRs) are transcription factors that regulate essential biological processes in response to cognate ligands. An important part of NR function involves ligand‐induced conformational changes that recruit coregulator proteins to the activation function surface (AFS), ~15 Å away from the ligand‐binding pocket. Ligands must communicate with the AFS to recruit appropriate coregulators and elicit different transcriptional outcomes, but this communication is poorly understood. These studies illuminate allosteric communication networks underlying activation of liver receptor homolog‐1 (LRH‐1), a NR that regulates development, metabolism, cancer progression, and intestinal inflammation. Using >100 μs of all‐atom molecular dynamics simulations involving 74 LRH‐1 complexes, we identify distinct signaling circuits used by active and inactive ligands for AFS communication. Inactive ligands communicate via strong, coordinated motions along paths through the receptor to the AFS. Activating ligands disrupt the “inactive” circuit and induce connectivity with a second allosteric site. Ligand‐contacting residues in helix 7 help mediate the switch between circuits, suggesting new avenues for developing LRH‐1‐targeted therapeutics. We also elucidate aspects of coregulator signaling, showing that localized, destabilizing fluctuations are induced by inappropriate ligand‐coregulator pairings. These studies have uncovered novel features of LRH‐1 allostery, and the quantitative approach used to analyze many simulations provides a framework to study allosteric signaling in other receptors.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biochemistry, Emory University, Atlanta, Georgia, USA.
- Department of Genome Biology, Centre for Genomic Regulation, Barcelona, Spain.
- Department of Molecular Biology and Biochemistry, Pennsylvania State University, State College, Pennsylvania, USA.
ORCID profiles: Suzanne G Mays, Eric A Ortlund, C Denise Okafor
Funding
- NIDDK NIH HHS
- Burroughs Wellcome Fund
- National Institutes of Health
Cite
APA
Mays, S. G., Hercules, D., Ortlund, E. A., & Okafor, C. D. (2023). The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits. Protein Science, 32(10). https://doi.org/10.1002/pro.4754
Vancouver
Mays SG, Hercules D, Ortlund EA, Okafor CD. The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits. Protein Science. 2023;32(10). doi:10.1002/pro.4754
BibTeX
@article{Mays2023,
author = {Mays, Suzanne G and Hercules, David and Ortlund, Eric A and Okafor, C Denise},
title = {The nuclear receptor LRH ‐1 discriminates between ligands using distinct allosteric signaling circuits},
journal = {Protein Science},
year = {2023},
volume = {32},
number = {10},
doi = {10.1002/pro.4754}
}
EUVIMED